OSE Immunotherapeutics receives authorization for phase 1 clinical trial of its multi-target multi-variant COVID-19 vaccine
CoVepiT is a SARS-COV-2 vaccine activating T cell defenses through CD8 T-cell multiepitope* responses. CoVepiT epitopes are selected from 11... View Article
Immunotherapeutics in the fight against liver cancer: a world first for Rennes University Hospital and the Eugène Marquis Centre
With over 10,000 new cases every year, liver cancer is one of the most difficult cancers to treat. In Rennes,... View Article
France Relance | Achievements in the Grand Ouest region
Source: Press release – France Relance This year, the COVID-19 health crisis has done much to reinforce the conviction that... View Article
AFFILOGIC | Relocating its production capabilities
Winner of the French Resilience Call for Proposals in late 2020, Affilogic, a cluster member specialising in the discovery and... View Article
New member | Apo Tech Care
Apo Tech Care’s mission is to be the facilitator in implementing a real care 4.0 (participative, personalized, preventive and predictive),... View Article
France Relance | GoLiver Therapeutics awarded a grant of 1 M€ to produce regenerative cells
The aim of this project is to manufacture, in France, a cell therapy product from pluripotent stem cells for the... View Article
Valneva Joins Euronext SBF 120 and CAC Mid 60 Indices
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
New member | Althenas
Althenas supports AI & health projects of public and private organizations, from consulting advice to complete project management. The company... View Article
OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp... View Article
New member | Orthopus
ORTHOPUS designs open-source technical aids for physical disabilities at fair prices. Based in Nantes, this company develops two ranges of... View Article